126 related articles for article (PubMed ID: 31381591)
1. Prevalence of potential drug-drug interactions in Swedish pediatric outpatients.
Holm J; Eiermann B; Kimland E; Mannheimer B
PLoS One; 2019; 14(8):e0220685. PubMed ID: 31381591
[TBL] [Abstract][Full Text] [Related]
2. A limited number of prescribed drugs account for the great majority of drug-drug interactions.
Holm J; Eiermann B; Eliasson E; Mannheimer B
Eur J Clin Pharmacol; 2014 Nov; 70(11):1375-83. PubMed ID: 25190295
[TBL] [Abstract][Full Text] [Related]
3. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
Toivo TM; Mikkola JA; Laine K; Airaksinen M
Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
[TBL] [Abstract][Full Text] [Related]
4. Drug-drug interactions in pediatric oncology patients.
Balk TE; van der Sijs IH; van Gelder T; Janssen JJB; van der Sluis IM; van Leeuwen RWF; Engels FK
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28205376
[TBL] [Abstract][Full Text] [Related]
5. [Few drugs dominate among clinically important interactions. Swedish register study lists problem drugs].
Holm J; Eiermann B; Eliasson E; Mannheimer B
Lakartidningen; 2015 Mar; 112():. PubMed ID: 25825885
[TBL] [Abstract][Full Text] [Related]
6. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register.
Johnell K; Klarin I
Drug Saf; 2007; 30(10):911-8. PubMed ID: 17867728
[TBL] [Abstract][Full Text] [Related]
7. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.
Lin CF; Wang CY; Bai CH
Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763
[TBL] [Abstract][Full Text] [Related]
8. Countrywide prevalence of critical drug interactions in Hungarian outpatients: a retrospective analysis of pharmacy dispensing data.
Somogyi-Végh A; Ludányi Z; Erdős Á; Botz L
BMC Pharmacol Toxicol; 2019 May; 20(1):36. PubMed ID: 31151485
[TBL] [Abstract][Full Text] [Related]
9. Clinically relevant drug-drug interactions among elderly people with dementia.
Sönnerstam E; Sjölander M; Lövheim H; Gustafsson M
Eur J Clin Pharmacol; 2018 Oct; 74(10):1351-1360. PubMed ID: 29967921
[TBL] [Abstract][Full Text] [Related]
10. Clinically relevant potential drug-drug interactions among outpatients: A nationwide database study.
Jazbar J; Locatelli I; Horvat N; Kos M
Res Social Adm Pharm; 2018 Jun; 14(6):572-580. PubMed ID: 28716467
[TBL] [Abstract][Full Text] [Related]
11. Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance.
Tulner LR; Frankfort SV; Gijsen GJ; van Campen JP; Koks CH; Beijnen JH
Drugs Aging; 2008; 25(4):343-55. PubMed ID: 18361544
[TBL] [Abstract][Full Text] [Related]
12. Laboratory tests in the clinical risk management of potential drug-drug interactions: a cross-sectional study using drug-dispensing data from 100 Dutch community pharmacies.
Geerts AF; De Koning FH; De Smet PA; Van Solinge WW; Egberts TC
Drug Saf; 2009; 32(12):1189-97. PubMed ID: 19916585
[TBL] [Abstract][Full Text] [Related]
13. Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care.
Andersson ML; Böttiger Y; Lindh JD; Wettermark B; Eiermann B
Eur J Clin Pharmacol; 2013 Mar; 69(3):565-71. PubMed ID: 22752671
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of potential drug-drug interactions in outpatients of a general hospital in China: a retrospective investigation.
Ren W; Liu Y; Zhang J; Fang Z; Fang H; Gong Y; Lv X
Int J Clin Pharm; 2020 Aug; 42(4):1190-1196. PubMed ID: 32488437
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.
Gagne JJ; Maio V; Rabinowitz C
J Clin Pharm Ther; 2008 Apr; 33(2):141-51. PubMed ID: 18315779
[TBL] [Abstract][Full Text] [Related]
16. Time-Trends of Drug-Drug Interactions among Elderly Outpatients in the Piedmont Region (Italy): A Population-Based Study.
Galai E; Scotti L; Gilardetti M; Ucciero A; Ferrante D; Poluzzi E; Genazzani AA; Barone-Adesi F
Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742605
[TBL] [Abstract][Full Text] [Related]
17. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.
Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI
J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271
[TBL] [Abstract][Full Text] [Related]
18. Pharmacoepidemiological study of drug-drug interactions in onco-hematological pediatric patients.
Fernández de Palencia Espinosa MA; Díaz Carrasco MS; Fuster Soler JL; Ruíz Merino G; De la Rubia Nieto MA; Espuny Miró A
Int J Clin Pharm; 2014 Dec; 36(6):1160-9. PubMed ID: 25204258
[TBL] [Abstract][Full Text] [Related]
19. Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis.
Dechanont S; Maphanta S; Butthum B; Kongkaew C
Pharmacoepidemiol Drug Saf; 2014 May; 23(5):489-97. PubMed ID: 24616171
[TBL] [Abstract][Full Text] [Related]
20. Potential drug-drug interactions in paediatric outpatient prescriptions in Nigeria and implications for the future.
Oshikoya KA; Oreagba IA; Godman B; Oguntayo FS; Fadare J; Orubu S; Massele A; Senbanjo IO
Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1505-1515. PubMed ID: 27592636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
